Objective: The present study observed the therapeutic effect and possible side effects of Q-switch 1064-nm laser with large-spot and low-energy technology in the treatment of patients with combined freckles and chloasma.
Methods: A Q1064-nm laser with a large-spot diameter of 6-8 mm, energy level of 2.0-3.3 J/cm, frequency of 10 Hz, and pulse width of 10 ns was employed for the treatment. Each patient underwent treatment 10-15 times, with an interval of 10-15 days each time. Facial care was administered before and after treatment; attention was paid to cleaning and moisturizing, avoiding light, and using sunscreens strictly. The therapeutic effects were observed and evaluated.
Results: Freckles basically subsided (effective rate = 100%) and chloasma faded (effective rate = 39.4%). Furthermore, whitening and delicacy improvement were observed in the surrounding normal skin area. After laser treatment, confocal laser scanning microscopy revealed a large number of melanin particles in the upper part of the granular layer. Moreover, the amount of melanin in the middle and lower parts of the basal layer and spinous layer was significantly decreased. None of the patients developed postinflammatory pigmentation.
Conclusion: In the treatment of freckles with chloasma, Q 1064-nm laser large-spot, low-energy technology not only removed freckles and faded chloasma but, most importantly, also reduced the incidence of postinflammatory pigmentation and improved patient satisfaction. This provided new methods and ideas for freckle laser treatment.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335754 | PMC |
http://dx.doi.org/10.1155/2023/4081427 | DOI Listing |
ArXiv
September 2024
Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA.
Previously, a synchrotron-based horizontal proton beamline (87.2 MeV) was successfully commissioned to deliver radiation doses in FLASH and conventional dose rate modes to small fields and volumes. In this study, we developed a strategy to increase the effective radiation field size using a custom robotic motion platform to automatically shift the positions of biological samples.
View Article and Find Full Text PDFJ Eur Acad Dermatol Venereol
June 2024
Laser Department, Department for Dermatology und Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Background: Pulsed dye lasers (PDL) are currently the first-line treatment of port-wine birthmarks (PWB). Due to high maintenance costs and instable technology, alternative methods are needed.
Objectives: To compare clinical outcomes of a variable-sequenced, long-pulsed 532-nm potassium titanyl-phosphate (KTP) laser and PDL on treating PWB.
Exp Dermatol
May 2024
Department of Dermatology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Melasma is a common condition of hyperpigmented facial skin. Picosecond lasers are reported to be effective for the treatment of melasma. We aimed to identify the most effective therapeutic mode and elucidate the potential molecular mechanisms of picosecond lasers for the treatment of melasma.
View Article and Find Full Text PDFJ Cosmet Dermatol
July 2024
Laser Department, Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Background: Pulsed-dye lasers (PDL) are one of the standard therapies for rosacea, but alternatives are needed.
Aims: To compare the efficacy and safety of the variable-sequenced, large-spot 532 nm KTP laser to the 595 nm PDL in treating rosacea.
Materials And Methods: A prospective, controlled, evaluator-blinded study.
J Clin Med
February 2024
Dermatology, Laser, and Vein Specialists of the Carolinas, 1918 Randolph Rd., Suite 550, Charlotte, NC 28207, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!